Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Angiotec tablets (20 mg enalapril) Produced by JPM / Jordan versus Renitec® tablets (20 mg enalapril) Produced by Merck Sharp & Dohme / UK, in healthy subjects under fasting condition.

drug protocol number
Jun-17
drug sponsor
SFDA
drug study
Angiotec
drug trial site
Saudi Ajal
drug status
Ongoing
drug phase